creactive protein and lung cancer

... polymorphism and lung cancer risk. Cancer Epi- demiol Biomarkers Prev 2001; 10: 911-2. 26. Chen S, Tang D, Xue K, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in ... gene XPD and risk of primary lung cancer. Lung Cancer 2002; 36: 15-6. 28. Harms C, Salama SA, Sierra-Torres CH, et al. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. ... repair gene XPD poly- morphism and lung cancer risk: a meta-analysis. Lung Cancer 2004; 46: 1-10. 51. Benhamou S, Sarasin A. ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review. Am J...

Ngày tải lên: 31/10/2012, 14:59

Ngày tải lên: 22/03/2014, 16:21

Ngày tải lên: 07/08/2014, 23:22

Ngày tải lên: 10/08/2014, 10:21

Ngày tải lên: 12/08/2014, 14:20

Ngày tải lên: 10/08/2014, 10:21

Ngày tải lên: 10/08/2014, 10:21

... Affected by Lung Cancer The following therapies are used to treat bones affected by lung cancer: ã Lung cancer treatment. The prompt initiation of appropriate therapy for lung cancer is ... The Bone and Cancer Foundation The mission of The Bone and Cancer Foundation is to: ã Provide information to cancer patients and family member on the causes and current ... information can be found in the Bone and Cancer Foundation publication “Osteonecrosis of the Jaw – Information for Cancer Patients” available online at www.boneandcancerfoundation.org or by calling...

Ngày tải lên: 15/02/2014, 05:20

... NICE Guideline – lung cancer 4 Introduction In England and Wales, nearly 29,000 deaths were attributed to lung cancer in 2002. Lung cancer is the most common cause of cancer death for men, ... account for 60% of lung cancer cases. In women, lung cancer is the second most common cause of cancer death after breast cancer. Survival rates for lung cancer are very poor. In England, for patients ... needed into the symptoms and signs associated with early- and late-stage lung cancer and the factors associated with delay in presentation. For patients diagnosed with lung cancer, analysis should...

Ngày tải lên: 15/03/2014, 00:20

... between smoking and different histological types of lung cancer 4-18 4-11 Lung cancer deaths attributable to tobacco smoking in certain countries 4-24 5-1 Epidemiologic studies on ETS and lung cancer ... and active smokers 3-43 4-1 Main characteristics of major cohort studies on the relationship between smoking and cancer 4-6 4-2 Lung cancer mortality ratios prospective studies 4-8 4-3 Lung cancer ... risks of lung cancer in some large cohort studies among men smoking cigarettes and other types of tobacco 4-15 4-8 Age-adjusted lung cancer mortality ratios for males and females, by tar and nicotine...

Ngày tải lên: 15/03/2014, 01:20

... in every area except Iceland and ranged from 8 or more in Slovenia, Spain, France and Italy, to more than 14 in the Netherlands. The proportion of lung and bronchus cancers that did not have ... smoking and lung cancer varies by cell type, with the odds ratios historically largest for squamous and small cell carcinomas and somewhat FIGURE 2 –CONTINUED. 297INTERNATIONAL LUNG CANCER TRENDS ... Isere, Somme and Tarn); for Spain from Navarra and Tarragona; and for Switzerland (1983 on) from Basel, Geneva and Zurich. We used the data from Varese for Italy, from Eindhoven for the Nether- lands and...

Ngày tải lên: 22/03/2014, 17:20

... exhaust and lung cancer. Our purpose was to evaluate the relationship between quantitative estimates of exposure to diesel exhaust and lung cancer mortality after adjustment for smoking and other ... exposure–response relationship for diesel exhaust and lung cancer with adjustment for potential confounding from cigarette smoking and other risk factors for lung cancer. We conducted a cohort mortality ... exhaust and lung cancer mortality after adjustment for cigarette smoking and other potential confounding factors that were unavailable in the cohort study. Materials and Methods Cohort Design and...

Ngày tải lên: 22/03/2014, 17:20

... promoter and, subsequently, the relative expression of p73 iso- forms in lung cancer by using lung cancer cell lines and tumour samples. Sp1 was found to activate the transcription of TAp73c in lung cancer ... (CALU6), in the squamous lung cancer cell lines (HTB59, HTB58, and SKMES1), in the adenocarcinoma cell lines (CALU3, CRL5935, A549, and SKLU1), and in the large cell lung cancer cell line (CORL23). ... 19) of squamous cell lung cancer samples, and in 50% (13⁄ 26) of total lung cancer samples. Figure 4C shows TAp73 and Sp1 levels in representative squa- mous cell carcinoma and adenocarcinoma samples (Fig....

Ngày tải lên: 29/03/2014, 09:20

... blotting and dot blotting of the analytical density gradients (Figs 5 and 6). Fraction 1 represents the top of the gradient, and fraction 11 is the bottom of the gradient. Fractions 3 and 4 and fractions ... in fraction 4 (70%) and in fraction 6 (30%). Immunodetection of MRP1 in the absence (B) and in the presence (C) of treatment with MbCD. S and R stand for GLC4 (sensitive) and GLC4 ⁄ ADR (resistant) ... (2001) Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells. Eur J Pharmacol 421, 1–9. 56 Fernandez-Checa JC & Kaplowitz...

Ngày tải lên: 30/03/2014, 09:20

... was ≥ 85% in 59% and 68%, and < 50% in only 5% and 8% of arm A and B patients, respectively. Gemcitabine RDI was ≥ 85% in 33% and 74%, and < 50% in 23% and 0% of arm A and B patients, respectively. ... Tonato M: Gemcitabine and cisplatin versus mito- mycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. J Clin ... J Cancer 2001, 94:153-156. 2. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized...

Ngày tải lên: 18/06/2014, 15:20

... between small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) [1]. The molecular pathogenesis of lung cancer, as far as it has been deciphered, consists of genetic and epigenetic alterations, ... cell lung cancer and non-small cell lung cancer. J Carcinog 2006, 20:4. 28. Kargi A, Gurel D, Tuna B: The diagnostic value of TTF-1, CK 5/ 6, and p63 immunostaining in classification of lung ... chromosome condensation protein G was Table 1: Classification of significantly deregulated lung cancer genes in comparison to normal lung tissue with respect to cancer subtype and biological functions. functional...

Ngày tải lên: 18/06/2014, 15:20

... clinical and laboratory data, data analysis and interpretation, and drafted the manuscript. PP and LG participated in acquiring clinical and laboratory data, data analysis and data interpretation and ... methylation patterns in lung cancer. Seminars in Cancer Biology 2009, 19(3):181-187. 7. Costello JF, Fruhwald MC, Smiraglia DJ: Aberrant CpG-island methylation has non-random and tumour-type-specific ... diagnosis, prog- nosis and/ or detection of metastatic pot ential of tumors, including lung cancer. As the number of genes methy- lated in cancer is large and increasing, sensitive and robust multiplexed...

Ngày tải lên: 18/06/2014, 16:20

... small cell lung cancer (NSCLC) specimens and to correlate its mRNA or protein expression with patients’ clinico-pathological features. Materials and methods: Quantitative real-time PCR and immunohistochemistry ... information and final writing of the manuscript. VM, SS, PC and EB participated in acquiring clinical and laboratory data, data analysis and data interpretation and drafted the manuscript. MP and GVS ... in cancer pathology. Pathology 2007, 39:305-318. 20. Bremnes RM, Veve R, Hirsch FR, Franklin WA: The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung...

Ngày tải lên: 18/06/2014, 19:20

... Cathepsins K, L, and S activity profiles in human lung cancer. A) Different stages (I, II, and III) of lung cancer and normal lung tissues were obtained and prepared as described. 10 μg of protein were ... Cathepsins K, L, and S in Human Breast, Lung, and Cervical Cancer Binbin Chen and Manu O Platt * Abstract Background: Cathepsins K, L, and S are cysteine proteases upregulated in cancer and proteolyze ... differences in cathepsin K, L, and S activity profiles between breast, lung, and cervical tissue and changes to these profiles as the cancer stage increased. Ductal carcinoma breast cancers arise in the inner...

Ngày tải lên: 18/06/2014, 22:20